Skip to main content

previous disabled Page of 21
and
  1. Article

    Open Access

    Transcriptomic analysis identifies B-lymphocyte kinase as a therapeutic target for desmoplastic small round cell tumor cancer stem cell-like cells

    Desmoplastic small round cell tumor (DSRCT) is an aggressive pediatric cancer caused by the EWSR1-WT1 fusion oncoprotein. The tumor is refractory to treatment with a 5-year survival rate of only 15–25%, necess...

    Justin W. Magrath, Dane A. Flinchum, Alifiani B. Hartono in Oncogenesis (2024)

  2. Article

    Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1

    L. Venturutti, R. I. Cordo Russo, M. A. Rivas, M. F. Mercogliano, F. Izzo in Oncogene (2023)

  3. Article

    Open Access

    WDR5 facilitates recruitment of N-MYC to conserved WDR5 gene targets in neuroblastoma cell lines

    Collectively, the MYC family of oncoprotein transcription factors is overexpressed in more than half of all malignancies. The ability of MYC proteins to access chromatin is fundamental to their role in promoti...

    Leigh A. Bumpous, Kylie C. Moe, **g Wang, Logan A. Carver in Oncogenesis (2023)

  4. No Access

    Article

    IGF2BP1 regulates the cargo of extracellular vesicles and promotes neuroblastoma metastasis

    Neuroblastoma is a highly metastatic cancer, and thus is one of the leading causes of cancer-related mortalities in pediatric patients. More than 50% of NB cases exhibit 17q21-ter partial chromosomal gain, whi...

    Mayura R. Dhamdhere, Chethana P. Gowda, Vikash Singh, Zhenqiu Liu in Oncogene (2023)

  5. No Access

    Article

    HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer

    TSC-mTORC1 inhibition-mediated translational reprogramming is a major adaptation mechanism upon many stresses, such as low-oxygen, -ATP, and -amino acids. But how cancer cells hijack the adaptive pathway to su...

    Bei Liu, Jiaxi Zhang, Xue Meng, Shelly M. **e, Fang Liu, Heli Chen, Demin Yao in Oncogene (2023)

  6. Article

    Open Access

    Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions

    Exploring the relationship between various neurotransmitters and breast cancer cell growth has revealed their likely centrality to improving breast cancer treatment. Neurotransmitters play a key role in breast...

    Priya Jayachandran, Francesca Battaglin, Carly Strelez, Annika Lenz in Oncogene (2023)

  7. No Access

    Article

    DHODH inhibition impedes glioma stem cell proliferation, induces DNA damage, and prolongs survival in orthotopic glioblastoma xenografts

    Glioma stem cells (GSCs) promote tumor progression and therapeutic resistance and exhibit remarkable bioenergetic and metabolic plasticity, a phenomenon that has been linked to their ability to escape standard...

    Raffaella Spina, Ian Mills, Fahim Ahmad, Chixiang Chen, Heather M. Ames in Oncogene (2022)

  8. No Access

    Article

    STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential

    Signal transducer and activator of transcription 5 (STAT5) promotes cell survival and instigates breast tumor formation, and in the normal breast it also drives alveolar differentiation and lactogenesis. Howev...

    Meng Lin, Amy T. Ku, Jie Dong, Fei Yue, Weiyu Jiang, Ahmed Atef Ibrahim in Oncogene (2022)

  9. No Access

    Article

    Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment

    The brain–gut axis, a bidirectional network between the central and enteric nervous system, plays a critical role in modulating the gastrointestinal tract function and homeostasis. Recently, increasing evidenc...

    Francesca Battaglin, Priya Jayachandran, Carly Strelez, Annika Lenz in Oncogene (2022)

  10. No Access

    Article

    GSTM2 is a key molecular determinant of resistance to SG-ARIs

    Prostate cancer (PCa) continues to threaten men’s health, and treatment targeting the androgen receptor (AR) pathway is the major therapy for PCa patients. Several second-generation androgen receptor inhibitor...

    Chaohao Li, **peng Liu, Daheng He, Fengyi Mao, **ongjian Rao, Yue Zhao in Oncogene (2022)

  11. No Access

    Article

    Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer

    Co-occurrent KRAS and TP53 mutations define a majority of patients with pancreatic ductal adenocarcinoma (PDAC) and define its pro-metastatic proclivity. Here, we demonstrate that KRAS-TP53 co-alteration is assoc...

    Jashodeep Datta, Anna Bianchi, Iago De Castro Silva, Nilesh U. Deshpande in Oncogene (2022)

  12. No Access

    Article

    Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets

    Signet ring cell carcinoma (SRCC) is rare: about 10% of gastric cancer (GC) and 1% of colorectal cancer (CRC). SRCC is associated with poor prognosis, however the underlying molecular characteristics are unkno...

    Alberto Puccini, Kelsey Poorman, Fabio Catalano, Andreas Seeber in Oncogene (2022)

  13. No Access

    Article

    Targeting oncometabolism to maximize immunotherapy in malignant brain tumors

    Brain tumors result in significant morbidity and mortality in both children and adults. Recent data indicate that immunotherapies may offer a survival benefit after standard of care has failed for malignant br...

    Joshua D. Bernstock, Kyung-Don Kang, Neil V. Klinger, Hannah E. Olsen, Sam Gary in Oncogene (2022)

  14. No Access

    Article

    O-GlcNAc transferase regulates glioblastoma acetate metabolism via regulation of CDK5-dependent ACSS2 phosphorylation

    Glioblastomas (GBMs) preferentially generate acetyl-CoA from acetate as a fuel source to promote tumor growth. O-GlcNAcylation has been shown to be elevated by increasing O-GlcNAc transferase (OGT) in many can...

    Lorela Ciraku, Zachary A. Bacigalupa, **g Ju, Rebecca A. Moeller in Oncogene (2022)

  15. No Access

    Article

    HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin

    Transmembrane glycoprotein NMB (GPNMB) is a prognostic marker of poor outcome in patients with triple-negative breast cancer (TNBC). Glembatumumab Vedotin, an antibody drug conjugate targeting GPNMB, exhibits ...

    Marco Biondini, Alex Kiepas, Leeanna El-Houjeiri, Matthew G. Annis in Oncogene (2022)

  16. No Access

    Article

    SMARCA4 biology in alveolar rhabdomyosarcoma

    Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and phenocopies a muscle precursor that fails to undergo terminal differentiation. The alveolar subtype (ARMS) has the poorest prognosi...

    Narendra Bharathy, Megan M. Cleary, **-Ah Kim, Kiyo Nagamori in Oncogene (2022)

  17. No Access

    Article

    Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy

    Metastasis-initiating cells (MICs) display stem cell-like features, cause metastatic recurrences and defy chemotherapy, which leads to patients’ demise. Here we show that prostate and breast cancer patients ha...

    Anthony DiNatale, Ramanpreet Kaur, Chen Qian, Jieyi Zhang, Michael Marchioli in Oncogene (2022)

  18. No Access

    Article

    Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer

    Loss-of-function alterations of Neurofibromin 1 (NF1) activate RAS, a driver of colorectal cancer. However, the clinical implications of NF1 alterations are largely unknown. We performed a comprehensive molecular...

    Hiroyuki Arai, Andrew Elliott, Joshua Millstein, Joanne **u, Fang-Shu Ou in Oncogene (2022)

  19. No Access

    Article

    MZF1 mediates oncogene-induced senescence by promoting the transcription of p16INK4A

    Oncogene induced senescence is a tumor suppressing defense mechanism, in which the cell cycle-dependent protein kinase (CDK) inhibitor p16INK4A (encoded by the CDKN2A gene) plays a key role. We previously reporte...

    Dan Wu, Hua Tan, Weijun Su, Dongmei Cheng, Guanwen Wang, Juan Wang, Ding A. Ma in Oncogene (2022)

  20. No Access

    Article

    CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer

    Expression of β-crystallin B2 (CRYβB2) is elevated in African American (AA) breast tumors. The underlying mechanisms of CRYβB2-induced malignancy and the association of CRYβB2 protein expression with survival ...

    Yu Yan, Athira Narayan, Soonweng Cho, Zhiqiang Cheng, Jun O. Liu, Heng Zhu in Oncogene (2021)

previous disabled Page of 21